-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700

Benzinga·10/23/2026 20:01:42
Listen to the news
UBS analyst Kevin Caliendo maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $673 to $700.